Fig. 1From: Development and implementation of “Check of Medication Appropriateness” (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillanceFlow diagram of the quantitative evaluation. *4 preselected categories: drug use in renal insufficiency, drugs with high potential of QTc interval prolongation, drugs with a restricted indication or dosing and overruled very severe DDIsBack to article page